Motor cortex repetitive transcranial magnetic stimulation in fibromyalgia: a multicentre randomised controlled trial
British Journal of Anaesthesia · 2025
DOI: 10.1016/j.bja.2024.12.045 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Anaesthesia, 2025. Verfasst von Valquíria A Silva und 22 weiteren Autor:innen. Beteiligte Einrichtung: LIM 62 - Pain Center, Department of Neurology, São Paulo, Brazil; Service of Interdisciplinary Neuromodulation (SIN), Department and Institute of Psy…. Hauptthemen laut MEDLINE: Fibromyalgia, Transcranial Magnetic Stimulation, Motor Cortex. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MagVenture Inc, Universidade de São Paulo, Danish National Research Foundation.
Abstract (Originalsprache)
BACKGROUND: Despite affecting 2-4% of the population worldwide, fibromyalgia often remains refractory to treatment. Here we report the first international randomised double-blind, sham-controlled trial developed to assess the efficacy of repetitive transcranial magnetic stimulation (rTMS) as an add-on therapy for fibromyalgia. METHODS: Women aged ≥18 yr with fibromyalgia refractory to best available treatment were enrolled in Brazil, France, and Japan, and randomised to 10 Hz motor cortex (M1) rTMS, 3000 pulses day-1, or sham stimulation. This included 10 induction sessions over 2 weeks, followed by weekly maintenance (6 weeks), and fortnightly extended maintenance (8 weeks). Primary outcome was ≥50% pain reduction at week 8 compared with baseline. Secondary outcomes included pain interference, mood, global impression of change, and Fibromyalgia Impact Questionnaire (FIQ) scores at weeks 8 and 16. RESULTS: We randomised 101 women (mean age 48 [range 25-83] yr) into active (n=52) or sham (n=49) arms. Bayesian analysis revealed a 99.4% probability of ≥50% pain reduction at week 8 in the active group vs sham (odds ratio [OR] 3.04; 95% credible interval [95% CrI] 1.26-8.06), with a number needed to treat of 4.54. Frequentist analysis confirmed that relative pain reduction was higher in the active than in the sham group (40.4% vs 18.4%, P=0.028). At week 16, this probability reduced to 34.2% (OR 0.815; 95% CrI 0.313-2.1), but the likelihood of FIQ score reduction was 79.1%. The intervention appeared safe. CONCLUSIONS: Add-on M1-repetitive transcranial magnetic stimulation reduced pain intensity up to 8 weeks in women with fibromyalgia. Although analgesic effects waned, functional improvements remained during extended maintenance at week 16.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- LIM 62 - Pain Center, Department of Neurology, São Paulo, Brazil; Service of Interdisciplinary Neuromodulation (SIN), Department and Institute of Psychiatry, São Paulo, Brazil; Medical-Surgical Nursing Department, Unive…
- Center for Mathematics, Computation and Cognition, Federal University of ABC, São Paulo, Brazil.
- LIM 62 - Pain Center, Department of Neurology, São Paulo, Brazil.
- Service of Interdisciplinary Neuromodulation (SIN), Department and Institute of Psychiatry, São Paulo, Brazil; Mood Disorder Program (Pro-GRUDA), Department of Psychiatry, University of São Paulo, São Paulo, Brazil.
- Service of Interdisciplinary Neuromodulation (SIN), Department and Institute of Psychiatry, São Paulo, Brazil.
- Medicine School "Professor Orival Alves", State University of Western Paraná (UNIOESTE), Paraná, Brazil.
Förderung
- MagVenture Inc
- Universidade de São Paulo
- Danish National Research Foundation
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Teijin Pharma Limited
Zitieren
APA
Silva, V. A., Baptista, A. F., Fonseca, A. S., Carneiro, A. M., Brunoni, A. R., Carrilho, P. E. M., Lins, C. C., Kubota, G. T., Fernandes, A. M. B. L., Lapa, J. D. S., Dos Santos, L. M., Sasso, I., Monte-Silva, K., Poindessous-Jazat, F., Mori, N., Miki, K., Baltar, A., Tanaka, C., Teixeira, M. J., …, & Ciampi de Andrade, D. (2025). Motor cortex repetitive transcranial magnetic stimulation in fibromyalgia: a multicentre randomised controlled trial. British Journal of Anaesthesia. https://doi.org/10.1016/j.bja.2024.12.045
Vancouver
Silva VA, Baptista AF, Fonseca AS, Carneiro AM, Brunoni AR, Carrilho PEM, et al. Motor cortex repetitive transcranial magnetic stimulation in fibromyalgia: a multicentre randomised controlled trial. British Journal of Anaesthesia. 2025. doi:10.1016/j.bja.2024.12.045
BibTeX
@article{Silva2025,
author = {Silva, Valquíria A and Baptista, Abrahão F and Fonseca, Alessandra S and Carneiro, Adriana M and Brunoni, André R and Carrilho, Paulo E M and Lins, Catarina C and Kubota, Gabriel T and Fernandes, Ana Mércia B L and Lapa, Jorge D S and Dos Santos, Lucas M and Sasso, Ivo and Monte-Silva, Katia and Poindessous-Jazat, Frédérique and Mori, Nobuhiko and Miki, Kenji and Baltar, Adriana and Tanaka, Clarice and Teixeira, Manoel J and Hosomi, Koichi and Bouhassira, Didier and Attal, Nadine and Ciampi de Andrade, Daniel},
title = {Motor cortex repetitive transcranial magnetic stimulation in fibromyalgia: a multicentre randomised controlled trial},
journal = {British Journal of Anaesthesia},
year = {2025},
doi = {10.1016/j.bja.2024.12.045}
}
EUVIMED